Germany ayurvedic medicine tenders

Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure

Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Teriparatide (Atc Code: H05Aa02).

Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Teriparatide (Atc Code: H05Aa02).

Open House Discount Agreements 2025-14 - Guanfacine (Ret, Strengths: 1-4 Mg)

Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Bimatoprost (Atc Code: S01Ee03).

Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Bimatoprost (Atc Code: S01Ee03).

Open House Discount Contracts 2025-04

Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Golimumab (Atc Code According To Who: L04Ab06)

Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Flecainide (Atc Code According To Who: C01Bc04)

34. Generic Tender (Antibiotics+Bmg)